Literature DB >> 21697683

Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique.

Denis Querleu1, François Planchamp, Fabrice Narducci, Philippe Morice, Florence Joly, Catherine Genestie, Christine Haie-Meder, Laurence Thomas, Nathalie Quénel-Tueux, Emile Daraï, Pierre-Hervé Dorangeon, Henri Marret, Sophie Taïeb, Valérie Mazeau-Woynar.   

Abstract

INTRODUCTION: Endometrial cancer is the most common gynecological malignancy in France, with more than 6500 new cases in 2010. The French National Cancer Institute has been leading a clinical practice guidelines (CPG) project since 2008. This project involves the development and updating of evidence-based CPG in oncology.
OBJECTIVE: To develop CPG for diagnosis, treatment, and follow-up for patients with endometrial cancer.
METHODS: The guideline development process is based on systematic literature review and critical appraisal by experts, with feedback from specialists in cancer care delivery. The recommendations are thus based on the best available evidence and expert agreement.
RESULTS: Main recommendations include a routine pelvic magnetic resonance imaging in association with magnetic resonance imaging exploration of the para-aortic lymph nodes for locoregional staging, surgical treatment based on total hysterectomy with bilateral salpingo-oophorectomy with or without lymphadenectomy, and clinical examination for the follow-up. The initial laparoscopic surgical approach is recommended for stage I tumors. Lymphadenectomy and postoperative external radiotherapy are recommended for patients with high risk of recurrence but are restricted for patients with low or intermediate risk. If brachytherapy is indicated, it should be given at a high-dose rate rather than a low-dose rate. Routine imaging, biologic tests, and vaginal smears are not indicated for follow-up.

Entities:  

Mesh:

Year:  2011        PMID: 21697683     DOI: 10.1097/IGC.0b013e31821bd473

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  17 in total

1.  Patterns and utility of routine surveillance in high grade endometrial cancer.

Authors:  Jessica Hunn; Meaghan E Tenney; Ana I Tergas; Erin A Bishop; Kathleen Moore; William Watkin; Carolyn Kirschner; Jean Hurteau; Gustavo C Rodriguez; Ernst Lengyel; Nita K Lee; S Diane Yamada
Journal:  Gynecol Oncol       Date:  2015-03-30       Impact factor: 5.482

2.  How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey.

Authors:  Yoshihito Yokoyama; Kiyoshi Ito; Kiyoshi Takamatsu; Kazuhiro Takehara; Toru Nakanishi; Kenichi Harano; Hidemichi Watari; Nobuyuki Susumu; Daisuke Aoki; Toshiaki Saito
Journal:  Int J Clin Oncol       Date:  2015-03-06       Impact factor: 3.402

3.  Pre-operative MRI staging of endometrial cancer in a multicentre cancer network: can we match single centre study results?

Authors:  N D Soneji; N Bharwani; A Ferri; V Stewart; A Rockall
Journal:  Eur Radiol       Date:  2018-05-22       Impact factor: 5.315

4.  The risk and pattern of pelvic and para aortic lymph nodal metastasis in patients with intermediate and high risk endometrial cancer.

Authors:  Praveen S Rathod; P N Shakuntala; V R Pallavi; Rajashekar Kundaragi; B Shankaranand; C R Vijay; K Uma Devi; Uttam D Bafna
Journal:  Indian J Surg Oncol       Date:  2014-03-28

5.  Current and Future Status of Laparoscopy in Gynecologic Oncology.

Authors:  S Rimbach; K Neis; E Solomayer; U Ulrich; D Wallwiener
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-09       Impact factor: 2.915

6.  Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer.

Authors:  Gaiane M Rauch; Harmeet Kaur; Haesun Choi; Randy D Ernst; Ann H Klopp; Piyaporn Boonsirikamchai; Shannon N Westin; Leonardo P Marcal
Journal:  Radiographics       Date:  2014 Jul-Aug       Impact factor: 5.333

7.  Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer.

Authors:  Sokbom Kang; Zachary Thompson; E Claire McClung; Reem Abdallah; Jae K Lee; Jesus Gonzalez-Bosquet; Robert M Wenham; Hye Sook Chon
Journal:  Int J Gynecol Cancer       Date:  2018-02       Impact factor: 3.437

8.  Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients.

Authors:  I Ríos; A Rovirosa; C Ascaso; I Valduvieco; A Herreros; L Castilla; S Sabater; K Holub; J Pahisa; A Biete; M Arenas
Journal:  Clin Transl Oncol       Date:  2015-12-11       Impact factor: 3.405

9.  Identification of microRNA expression profile related to lymph node status in women with early-stage grade 1-2 endometrial cancer.

Authors:  Geoffroy Canlorbe; Zhe Wang; Enora Laas; Sofiane Bendifallah; Mathieu Castela; Marine Lefevre; Nathalie Chabbert-Buffet; Emile Daraï; Selim Aractingi; Céline Méhats; Marcos Ballester
Journal:  Mod Pathol       Date:  2016-02-05       Impact factor: 7.842

10.  An external validation study of nomograms designed to predict isolated loco-regional and distant endometrial cancer recurrences: how applicable are they?

Authors:  S Bendifallah; G Canlorbe; E Raimond; L Bazire; F Huguet; O Graesslin; R Rouzier; E Darai; M Ballester
Journal:  Br J Cancer       Date:  2013-08-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.